Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001819
Filing Date
2025-02-27
Accepted
2025-02-27 16:30:47
Documents
95
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acrs-20241231x10k.htm   iXBRL 10-K 3130448
2 EX-10.21 acrs-20241231xex10d21.htm EX-10.21 101987
3 EX-10.24 acrs-20241231xex10d24.htm EX-10.24 256237
4 EX-10.26 acrs-20241231xex10d26.htm EX-10.26 678191
5 EX-10.27 acrs-20241231xex10d27.htm EX-10.27 74843
6 EX-10.28 acrs-20241231xex10d28.htm EX-10.28 113207
7 EX-19.1 acrs-20241231xex19d1.htm EX-19.1 130791
8 EX-23.1 acrs-20241231xex23d1.htm EX-23.1 2340
9 EX-31.1 acrs-20241231xex31d1.htm EX-31.1 9549
10 EX-31.2 acrs-20241231xex31d2.htm EX-31.2 9666
11 EX-32.1 acrs-20241231xex32d1.htm EX-32.1 9270
12 GRAPHIC acrs-20241231x10k002.jpg GRAPHIC 67358
13 GRAPHIC acrs-20241231xex19d1001.jpg GRAPHIC 10553
  Complete submission text file 0001558370-25-001819.txt   13124783

Data Files

Seq Description Document Type Size
14 EX-101.SCH acrs-20241231.xsd EX-101.SCH 58617
15 EX-101.CAL acrs-20241231_cal.xml EX-101.CAL 68440
16 EX-101.DEF acrs-20241231_def.xml EX-101.DEF 240420
17 EX-101.LAB acrs-20241231_lab.xml EX-101.LAB 606081
18 EX-101.PRE acrs-20241231_pre.xml EX-101.PRE 427544
98 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20241231x10k_htm.xml XML 2044684
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37581 | Film No.: 25679585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)